Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > The future of Barium Sulphate as a Contrast Media

<< Previous

Bullboard Posts

Next >>

Post by WarrantOfficeron Dec 11, 2024 7:08am

132 Views

Post# 36356069

The future of Barium Sulphate as a Contrast Media

Fullerene and Micro Bubble development is in it's infancy and once fully developed, will probably entail a higher doseage cost. Approx 84% of the worlds population remains in a "developing country" IMO, there will always be a requirement for Barium Sulphate Contrast Media. Let's get our product to market....

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project